Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer

2018241 citationsJournal Articlegreen Open Access

Authors

Yoon Young Choi · Yonsei University Health System

Hyunki Kim · Seoul National University Bundang Hospital

Su‐Jin Shin · Hanyang University

Ha Yan Kim · Seoul National University Bundang Hospital

Jinae Lee · Yonsei University

Han‐Kwang Yang

Woo Ho Kim · Seoul National University

Abstract

MSI status and PD-L1 expression are clinically actionable biomarkers for stratifying patients and predicting benefit from adjuvant chemotherapy after D2 gastrectomy for stage II/III gastric cancer.

Topics & Keywords

Gastric Cancer Management and Outcomes Genetic factors in colorectal cancer Cholangiocarcinoma and Gallbladder Cancer Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Surgery

Volume 270, Issue 2, pp. 309-316

DOI: 10.1097/sla.0000000000002803

Field-Weighted Citation Impact: 19.61